Viking Therapeutics Inc - fluxo de caixa trimestral (NASDAQ:VKTX) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Fluxo de caixa operacional -31.18 M-52.33 M-47.06 M-94 M-85.29 M -278.69 M Fluxo de caixa de investimento 6.58 M63.24 M42.51 M160.03 M75.61 M 341.39 M Fluxo de caixa de financiamento 1 M349 K507 K480 K75.1 M 76.44 M Fluxo de caixa livre -31.18 M-52.33 M-47.06 M-94 M-85.29 M -278.69 M

Notícias

LLY Stock Down as FDA Asks for More Safety Data on Oral Obesity Pill

How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q1 Results?

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing

NVO Crashes 36% in 3 Months: Is This an Indication to Sell the Stock?

LLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships

3 Best Stocks Under $50 to Buy in April 2026, According to Analysts - TipRanks.com

Desenvolvedores de medicamentos para perda de peso se alinham para explorar o lucrativo mercado à medida que concorrência se acirra

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks